CD47 blockade as another immune checkpoint therapy for cancer

The role of CD47-often expressed on tumor cells-as a 'don't eat me' signal that inhibits macrophage phagocytosis is well established. But new work reveals a major role for other immune cell types-T cells and dendritic cells-in the anti-tumor effects of therapeutic CD47 blockade.